Previous Article | Next Article 
Journal of Virology, February 2000, p. 1101-1113, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Epstein-Barr Virus LMP2A-Induced B-Cell Survival in
Two Unique Classes of EµLMP2A Transgenic Mice
Robert G.
Caldwell,
R. Clark
Brown, and
Richard
Longnecker*
Department of Microbiology-Immunology,
Northwestern University Medical School, Chicago, Illinois 60611
Received 20 August 1999/Accepted 26 October 1999
Latent membrane protein 2A (LMP2A) is one of only two viral
proteins expressed during latent Epstein-Barr virus (EBV) infections in
human peripheral B cells. LMP2A blocks B-cell receptor (BCR) signal
transduction in vitro by modulation of the Syk and Lyn protein tyrosine
kinases. Five genetically unique LMP2A transgenic mouse lines
(EµLMP2A) with B-cell lineage expression of LMP2A were generated in
this study to analyze the importance of LMP2A expression in vivo. These
animals can be grouped into EµLMP2ABCR+ (TgB, Tg6, and
TgC) and EµLMP2ABCR
(Tg7 and TgE) lines based on B-cell
phenotype. LMP2A expression in bone marrow cells of
EµLMP2ABCR
lines was associated with a bypass of normal
B-lymphocyte developmental checkpoints inasmuch as immunoglobulin
light-chain gene rearrangement occurred in the absence of complete
immunoglobulin heavy-chain gene rearrangement. The resulting
BCR-negative B cells were able to exit the bone marrow and colonize
peripheral lymphoid organs. LMP2A expression in
EµLMP2ABCR+ lines was not associated with altered B-cell
development in a genetically wild-type background. When crossed into a
recombinase activating null (RAG
/
) genetic background,
LMP2A expression in either RAG
/
EµLMP2ABCR+ or RAG
/
EµLMP2ABCR
animals was able to provide a survival
signal to BCR-negative splenic B cells. Additionally, bone marrow cells
from all EµLMP2A animals were able to proliferate in response to
interleukin-7-dependent developmental signals in vitro. These studies
illustrate that LMP2A can provide a survival signal to BCR-negative B
cells in two different groups of EµLMP2A transgenic mice.
*
Corresponding author. Mailing address: Department of
Microbiology-Immunology, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611. Phone: (312) 503-0467. Fax: (312)
503-1339. E-mail: r-longnecker{at}nwu.edu.
Journal of Virology, February 2000, p. 1101-1113, Vol. 74, No. 3
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Anderson, L. J., Longnecker, R.
(2009). Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo. Blood
113: 108-116
[Abstract]
[Full Text]
-
Tsimbouri, P., Al-Sheikh, Y., Drotar, M. E., Cushley, W., Wilson, J. B.
(2008). Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival. J. Gen. Virol.
89: 2821-2832
[Abstract]
[Full Text]
-
Rovedo, M., Longnecker, R.
(2008). Epstein-Barr Virus Latent Membrane Protein 2A Preferentially Signals through the Src Family Kinase Lyn. J. Virol.
82: 8520-8528
[Abstract]
[Full Text]
-
Anderson, L. J., Longnecker, R.
(2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J. Gen. Virol.
89: 1563-1568
[Abstract]
[Full Text]
-
Guasparri, I., Bubman, D., Cesarman, E.
(2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood
111: 3813-3820
[Abstract]
[Full Text]
-
Fukuda, M., Longnecker, R.
(2007). Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway. J. Virol.
81: 9299-9306
[Abstract]
[Full Text]
-
Rechsteiner, M. P., Berger, C., Weber, M., Sigrist, J. A., Nadal, D., Bernasconi, M.
(2007). Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J. Gen. Virol.
88: 1454-1459
[Abstract]
[Full Text]
-
Rovedo, M., Longnecker, R.
(2007). Epstein-Barr Virus Latent Membrane Protein 2B (LMP2B) Modulates LMP2A Activity. J. Virol.
81: 84-94
[Abstract]
[Full Text]
-
Swanson-Mungerson, M., Bultema, R., Longnecker, R.
(2006). Epstein-Barr Virus LMP2A Enhances B-Cell Responses In Vivo and In Vitro. J. Virol.
80: 6764-6770
[Abstract]
[Full Text]
-
Brinkmann, M. M., Schulz, T. F.
(2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol.
87: 1047-1074
[Abstract]
[Full Text]
-
Lu, J., Lin, W.-H., Chen, S.-Y., Longnecker, R., Tsai, S.-C., Chen, C.-L., Tsai, C.-H.
(2006). Syk Tyrosine Kinase Mediates Epstein-Barr Virus Latent Membrane Protein 2A-induced Cell Migration in Epithelial Cells. J. Biol. Chem.
281: 8806-8814
[Abstract]
[Full Text]
-
Hamerman, J. A., Lanier, L. L.
(2006). Inhibition of Immune Responses by ITAM-Bearing Receptors. Sci Signal
2006: re1-re1
[Abstract]
[Full Text]
-
Ingham, R. J., Raaijmakers, J., Lim, C. S. H., Mbamalu, G., Gish, G., Chen, F., Matskova, L., Ernberg, I., Winberg, G., Pawson, T.
(2005). The Epstein-Barr Virus Protein, Latent Membrane Protein 2A, Co-opts Tyrosine Kinases Used by the T Cell Receptor. J. Biol. Chem.
280: 34133-34142
[Abstract]
[Full Text]
-
Swanson-Mungerson, M. A., Caldwell, R. G., Bultema, R., Longnecker, R.
(2005). Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to Autoantigen. J. Virol.
79: 7355-7362
[Abstract]
[Full Text]
-
Morrison, J. A., Raab-Traub, N.
(2005). Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling. J. Virol.
79: 2375-2382
[Abstract]
[Full Text]
-
Allen, M. D., Young, L. S., Dawson, C. W.
(2005). The Epstein-Barr Virus-Encoded LMP2A and LMP2B Proteins Promote Epithelial Cell Spreading and Motility. J. Virol.
79: 1789-1802
[Abstract]
[Full Text]
-
Morrison, J. A., Gulley, M. L., Pathmanathan, R., Raab-Traub, N.
(2004). Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma. Cancer Res.
64: 5251-5260
[Abstract]
[Full Text]
-
Sutkowski, N., Chen, G., Calderon, G., Huber, B. T.
(2004). Epstein-Barr Virus Latent Membrane Protein LMP-2A Is Sufficient for Transactivation of the Human Endogenous Retrovirus HERV-K18 Superantigen. J. Virol.
78: 7852-7860
[Abstract]
[Full Text]
-
Ikeda, A., Merchant, M., Lev, L., Longnecker, R., Ikeda, M.
(2004). Latent Membrane Protein 2A, a Viral B Cell Receptor Homologue, Induces CD5+ B-1 Cell Development. J. Immunol.
172: 5329-5337
[Abstract]
[Full Text]
-
O'Nions, J., Allday, M. J.
(2004). Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J. Gen. Virol.
85: 881-895
[Abstract]
[Full Text]
-
Portis, T., Dyck, P., Longnecker, R.
(2003). Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood
102: 4166-4178
[Abstract]
[Full Text]
-
Brinkmann, M. M., Glenn, M., Rainbow, L., Kieser, A., Henke-Gendo, C., Schulz, T. F.
(2003). Activation of Mitogen-Activated Protein Kinase and NF-{kappa}B Pathways by a Kaposi's Sarcoma-Associated Herpesvirus K15 Membrane Protein. J. Virol.
77: 9346-9358
[Abstract]
[Full Text]
-
Ikeda, A., Caldwell, R. G., Longnecker, R., Ikeda, M.
(2003). Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling. J. Virol.
77: 5529-5534
[Abstract]
[Full Text]
-
Portis, T., Longnecker, R.
(2002). Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development. J. Virol.
77: 105-114
[Abstract]
[Full Text]
-
Matskova, L., Ernberg, I., Pawson, T., Winberg, G.
(2001). C-Terminal Domain of the Epstein-Barr Virus LMP2A Membrane Protein Contains a Clustering Signal. J. Virol.
75: 10941-10949
[Abstract]
[Full Text]
-
Engels, N., Merchant, M., Pappu, R., Chan, A. C., Longnecker, R., Wienands, J.
(2001). Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) Employs the SLP-65 Signaling Module. JEM
194: 255-264
[Abstract]
[Full Text]
-
Winberg, G., Matskova, L., Chen, F., Plant, P., Rotin, D., Gish, G., Ingham, R., Ernberg, I., Pawson, T.
(2000). Latent Membrane Protein 2A of Epstein-Barr Virus Binds WW Domain E3 Protein-Ubiquitin Ligases That Ubiquitinate B-Cell Tyrosine Kinases. Mol. Cell. Biol.
20: 8526-8535
[Abstract]
[Full Text]
-
Merchant, M., Caldwell, R. G., Longnecker, R.
(2000). The LMP2A ITAM Is Essential for Providing B Cells with Development and Survival Signals In Vivo. J. Virol.
74: 9115-9124
[Abstract]
[Full Text]
-
Delecluse, H-J, Hammerschmidt, W
(2000). The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy. Mol. Pathol.
53: 270-279
[Abstract]
[Full Text]
-
Longan, L., Longnecker, R.
(2000). Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J. Gen. Virol.
81: 2245-2252
[Abstract]
[Full Text]